| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/05/2000 | EP0670719B1 Combination of atovaquone with proguanil for the treatment of protozoal infections |
| 04/05/2000 | EP0618811B1 Proteolytic mixture containing escharase and method of isolating same |
| 04/05/2000 | EP0568622B1 CORTICOTROPIN RELEASING FACTOR BINDING PROTEIN (CRF-bp) |
| 04/05/2000 | CN1249780A CASH (caspase homologue) with death effector domain, modulators of function of FAS receptors |
| 04/05/2000 | CN1249750A Crystalline hydrated sodium salt of (E)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1H-indole-2-carboxylic acid |
| 04/05/2000 | CN1249748A Small molecules useful in treatment of inflamatory disease |
| 04/05/2000 | CN1249743A Arylsulfonylamino hydroxamic acid derivs |
| 04/05/2000 | CN1249689A Stable solid preparation contg. vitamin D3 and tricalcium phosphate |
| 04/05/2000 | CN1249688A Self-regulated apoptosis of inflammatory cells by gene therapy |
| 04/05/2000 | CN1249681A N-oxides of heterocyclic esters, amides, thioesters, and ketones |
| 04/05/2000 | CN1249181A Universal medicinal cream and its preparing process |
| 04/05/2000 | CN1051086C Heterocycle-condensed morphinoid derivs. and use thereof |
| 04/05/2000 | CN1051079C Benzodiazepine derivs. their preparation method and pharmaceutical composition contg. same |
| 04/04/2000 | US6046341 An active drug having affinity for vasopressin and/or oxytocin receptors |
| 04/04/2000 | US6046340 Imidazole containing pseudodipeptide product and compositions containing the same |
| 04/04/2000 | US6046331 Imidazolones and their use in treating benign prostatic hyperplasia and other disorders |
| 04/04/2000 | US6046317 For screening for carrier status and diagnosis of predisposition for increased serum cholesterol or low density lipoprotein cholesterol level in humans |
| 04/04/2000 | US6046238 Method for treating or preventing the spread of acne vulgaris |
| 04/04/2000 | US6046236 Carbocyclic sulfonamides |
| 04/04/2000 | US6046234 Formulations and methods of reducing toxicity of antineoplastic agents |
| 04/04/2000 | US6046227 Useful in the treatment of type ii diabetes and obesity; a substituted pyrazine compound |
| 04/04/2000 | US6046222 Preventing or delaying the noninsulin dependent diabetes mellitus comprising administering to a host suffering from polycystic ovary syndrom or suffered from gestational diabetes a therapeutically effective amount of pioglitazone |
| 04/04/2000 | US6046221 Useful for reducing levels of tumor necrosis factor-alpha in a mammal |
| 04/04/2000 | US6046220 Propynyl or dienyl biaromatic compounds |
| 04/04/2000 | US6046219 Administering to the patient for treating the conditions mediated by collagen formation together with cell proliferation a hydroxypyridine derivative |
| 04/04/2000 | US6046215 A piperidinylbenzothiophenes useful for trating brain disorders |
| 04/04/2000 | US6046211 Amidino derivatives useful as nitric oxide synthase inhibitors |
| 04/04/2000 | US6046205 For treatment of venous insufficiency and of associated disorders, and also in the treatment of migraine |
| 04/04/2000 | US6046195 Useful in the treatment or prevention of pain, inflammation, migraine, emesis and postherpetic neuralgia |
| 04/04/2000 | US6046188 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease |
| 04/04/2000 | US6046186 Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use |
| 04/04/2000 | US6046183 Synergistic mixture of finasteride and doxazosin |
| 04/04/2000 | US6046180 NAALADase inhibitors |
| 04/04/2000 | US6046175 Procedure to block the replication of reverse transcriptase dependent viruses by the use of inhibitors of deoxynucleotides synthesis |
| 04/04/2000 | US6046162 Suppression of cell proliferation by decorin |
| 04/04/2000 | US6046159 Formulations and methods of reducing toxicity of antineoplastic agents |
| 04/04/2000 | US6046157 Modulation of TGF-β by recombinant TGF-β type II receptor polypeptides |
| 04/04/2000 | US6046049 Compound 8 to 30 nucleobases in length targeted to 3' untranslated region of nucleic acid which encodes human phosphatidyl inositol 3' kinase p110 delta isoform found in leukocytes; diagnosis, treatment of related diseases |
| 04/04/2000 | US6046015 Modulating Robo: ligand interactions |
| 04/04/2000 | US6045997 Materials and methods relating to the identification and sequencing of the BRCA2 cancer susceptibility gene and uses thereof |
| 04/04/2000 | US6045990 Inclusion of apoptotic regulators in solutions for cell storage at low temperature |
| 04/04/2000 | US6045827 Treatment of equine laminitis |
| 04/04/2000 | US6045826 Antioxidant/antiaging medicinal or cosmetic mixture for skin disorder prophylaxis |
| 04/04/2000 | US6045797 Treatment or diagnosis of diseases or conditions associated with a BLM domain |
| 04/04/2000 | US6045795 Methods and compositions for ameliorating the symptoms of sepsis |
| 04/04/2000 | US6045792 Human proteins kinases |
| 04/04/2000 | CA2107432C Quaternary basic amides, method of preparing them and pharmaceutical compositions in which they are present |
| 04/04/2000 | CA1340948C Peptidylaminodiols |
| 04/04/2000 | CA1340940C Peptidylaminodiols |
| 03/30/2000 | WO2000017644A1 Ndp |
| 03/30/2000 | WO2000017394A1 Polymorphisms in the human alpha4 integrin subunit gene, suitable for diagnosis and treatment of integrin ligand mediated diseases |
| 03/30/2000 | WO2000017393A1 Polymorphisms in the human beta1 integrin subunit gene, suitable for diagnosis and treatment of integrin ligand mediated diseases |
| 03/30/2000 | WO2000017392A1 Polymorphisms in the human vcam-1 gene, suitable for diagnosis and treatment of vcam-1 ligand mediated diseases |
| 03/30/2000 | WO2000017374A1 Retroviral particles protected against complement mediated destruction |
| 03/30/2000 | WO2000017371A1 Polynucleotide constructs and uses thereof |
| 03/30/2000 | WO2000017370A1 HUMAN COMPLEMENT C3-DEGRADING POLYPEPTIDE FROM $i(STREPTOCOCCUS PNEUMONIAE) |
| 03/30/2000 | WO2000017366A2 Pharmaceutical composition for the pre-treatment of a patient in need of drug or pro-drug |
| 03/30/2000 | WO2000017357A1 Methods and compositions relating to egf-repeat-containing polypeptides |
| 03/30/2000 | WO2000017354A1 Human isre-binding protein |
| 03/30/2000 | WO2000017351A1 New human hepatoma-derived growth factor encoding sequence and polypeptide encoded by such dna sequence and producing method thereof |
| 03/30/2000 | WO2000017348A1 G protein-coupled receptor agonists or antagonists |
| 03/30/2000 | WO2000017346A2 Hairpin hybridizer molecules for modulation of gene expression |
| 03/30/2000 | WO2000017228A2 Stereoselective process for enalapril |
| 03/30/2000 | WO2000017222A1 31 human secreted proteins |
| 03/30/2000 | WO2000017211A1 Phosphonic acids derivatives as inhibitors of ptp-1b |
| 03/30/2000 | WO2000017204A1 INHIBITORS OF p38 |
| 03/30/2000 | WO2000017203A1 Pyrrolopyrimidines as protein kinase inhibitors |
| 03/30/2000 | WO2000017202A1 4-aminopyrrolopyrimidines as kinase inhibitors |
| 03/30/2000 | WO2000017191A2 N-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them |
| 03/30/2000 | WO2000017184A1 Hydroxyflavone derivatives as tau protein kinase 1 inhibitors |
| 03/30/2000 | WO2000017176A2 Benzoylguanidine derivatives with advantageous properties, method for producing them and their use in the production of medicaments |
| 03/30/2000 | WO2000017175A1 INHIBITORS OF p38 |
| 03/30/2000 | WO2000017173A1 Benzoxazine and benzothiazine derivatives and their use in medicines |
| 03/30/2000 | WO2000017164A1 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines as cetp inhibitors |
| 03/30/2000 | WO2000017161A1 Cyclic ester or amide derivatives |
| 03/30/2000 | WO2000017133A2 Lta4 hydrolase inhibitors |
| 03/30/2000 | WO2000016814A1 Medicinal aerosol formulation |
| 03/30/2000 | WO2000016794A1 Neuroimmunophilins for selective neuronal radioprotection |
| 03/30/2000 | WO2000016781A1 Chk1 kinase inhibitors |
| 03/30/2000 | WO2000016772A1 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 03/30/2000 | WO2000016769A1 ACTIVE ENANTIOMER OF RARη-SPECIFIC AGONIST |
| 03/30/2000 | WO2000016767A1 Hydroxamate-containing cysteine and serine protease inhibitors |
| 03/30/2000 | WO2000016764A2 Pharmaceutical compositions comprising derivatives of sulphur acids |
| 03/30/2000 | WO2000016755A2 Antiviral combinations of lamivudine and adefovir |
| 03/30/2000 | WO2000016750A1 Pharmaceutical composition for the treatment of acute disorders |
| 03/30/2000 | WO2000016632A2 Environmentally benign crop protection agents |
| 03/30/2000 | WO2000016624A1 Safe and effective biofilm inhibitory compounds and health-related uses thereof |
| 03/30/2000 | WO2000016623A1 Antifouling agents |
| 03/30/2000 | WO2000009711A8 ISOLATED AND PURIFIED HUMAN SOLUBLE GUANYLYLCYCLASE α1/β1 (hsGCα1/β1) |
| 03/30/2000 | WO2000007576A3 INHIBITORS OF TYPE 3 3α-HYDROSTEROID DEHYDROGENASE |
| 03/30/2000 | WO2000000609A3 Molecules associated with apoptosis |
| 03/30/2000 | WO2000000483A9 Tubulin binding compounds (cobra) |
| 03/30/2000 | WO2000000120A9 Methods and transdermal compositions for pain relief |
| 03/30/2000 | WO1999066959A9 Compositions and methods for delivery of genetic material for altering neuronal growth, regeneration, and survival |
| 03/30/2000 | WO1999066918A9 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |
| 03/30/2000 | WO1999065449A3 INHIBITORS OF TRANSCRIPTION FACTOR NF-λB |
| 03/30/2000 | WO1999064593A3 Cell cycle regulation proteins |
| 03/30/2000 | WO1999062536A3 Pharmaceutical formulations for igf/igfbp |
| 03/30/2000 | WO1999061608A3 Polypeptides from creb binding protein and related protein p300 for use in transcriptional regulation |
| 03/30/2000 | WO1999053055A3 Therapeutic agent for ngf |